CIS
BSX icon

Capital International Sarl’s Boston Scientific BSX Stock Holding History

Capital International Sarl’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.76M Sell
228,575
-50,763
-18% -$2.76M 0.14% 117
2026
Q1 		$17.5M Sell
279,338
-136,380
-33% -$10.9M 0.29% 86
2025
Q4 		$39.6M Buy
415,718
+87,427
+27% +$8.57M 0.64% 45
2025
Q3 		$32.1M Sell
328,291
-8,341
-2% -$864K 0.55% 52
2025
Q2 		$36.2M Buy
336,632
+18,821
+6% +$1.9M 0.69% 41
2025
Q1 		$32.1M Buy
317,811
+42,377
+15% +$4.27M 0.73% 39
2024
Q4 		$24.6M Buy
275,434
+144,631
+111% +$12.7M 0.57% 49
2024
Q3 		$11M Buy
130,803
+50,332
+63% +$3.97M 0.28% 89
2024
Q2 		$6.2M Buy
80,471
+13,648
+20% +$999K 0.19% 111
2024
Q1 		$4.58M Buy
+66,823
New +$4.3M 0.15% 130
2020
Q4 		– Sell
-33,287
Closed -$1.27M – 230
2020
Q3 		$1.27M Sell
33,287
-3,221
-9% -$124K 0.16% 127
2020
Q2 		$1.28M Buy
36,508
+10,181
+39% +$367K 0.17% 118
2020
Q1 		$859K Sell
26,327
-639
-2% -$25K 0.16% 120
2019
Q4 		$1.22M Buy
+26,966
New +$1.13M 0.19% 119

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Sarl's BSX Position: Q2 2026 in Review

Capital International Sarl reduced its Boston Scientific (BSX) stake by 18% in Q2 2026, selling an estimated $2.76M and leaving 228,575 shares worth $9.76M. The position accounts for 0.14% of the portfolio, ranked #117.

Capital International Sarl first reported a position in BSX in Q4 2019 and has held it in 14 quarters since. The position peaked at $39.6M in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital International Sarl held 228,575 shares of Boston Scientific worth $9.76M as of Q2 2026.
  • Capital International Sarl sold 50,763 Boston Scientific shares in Q2 2026, an estimated $2.76M.
  • Boston Scientific made up 0.14% of Capital International Sarl's portfolio in Q2 2026, its #117 holding.
  • Capital International Sarl first reported a position in Boston Scientific in Q4 2019 and has held it in 14 quarters since.
  • Capital International Sarl's Boston Scientific position peaked at $39.6M in Q4 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.